vimarsana.com

Latest Breaking News On - Hospital bonn - Page 2 : vimarsana.com

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

Mind, Body & Heart

In this process, the typical elongated sperm cells are formed from round germ cells. This enormous change in shape requires the fine tuned reorganisation of specialised structural proteins.

Nerve cells can detect small numbers of thing

<p>When two, three or four apples are placed in front of us, we are able to recognize the number of apples very quickly. However, we need significantly more time if there are five or more apples and we often also guess the wrong number. In fact, the brain does actually register smaller numbers of things differently than larger ones. This has been demonstrated in a recent study by the University of T&uuml;bingen, University of Bonn and the University Hospital Bonn. The results were published in the magazine &ldquo;Nature Human Behaviour.&rdquo;&nbsp;</p>

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.